Adipose Stem Cell Secretion Composition for Lasting Hair and Skin Renewal

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing treatments for hair growth and skin/scalp rejuvenation using adipose-derived stem cell secretions do not provide lasting effects after the treatment is ended.

Innovation Solution

A pharmaceutical composition for topical administration using adipose stem cell secretions, administered at a specific dose of 0.3 to 0.6 μg of protein abundance per site, promotes continuous effects on scalp, skin, and hair modification, including hair growth rate and thickness, even after treatment cessation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If adipose-derived stem cell secretion is administered for hair growth and skin rejuvenation, then hair increasing effect and skin modification are achieved during treatment, but the effect disappears when treatment ends

Engineering Contradiction:

Improveduration of hair increasing effectVSAvoidsustainability of treatment effect

Core Design Contradiction:

Duration of action of moving objectVSReliability

Solution Approach 1:

The patent applies preliminary action by administering adipose-derived stem cell secretion at a specific dose (0.3 to 0.6 μg protein abundance per site) before the desired effect is fully achieved, establishing a foundation for sustained action. This preliminary dosing strategy ensures that the treatment effect is not merely temporary but establishes long-lasting biological modification in the scalp and skin tissues.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent utilizes parameter changes by precisely controlling the dose parameter of adipose-derived stem cell secretion within the specific range of 0.3 to 0.6 μg protein abundance per site. This optimized parameter range is critical for achieving both immediate effects and long-lasting benefits, transforming the temporary effect into a sustained treatment outcome.

Inventive Principle:

Principle #35Parameter changes

2Productivity

If higher dose of adipose stem cell secretion is administered, then faster hair growth and better skin regeneration are achieved, but increased cost and potential side effects occur

Engineering Contradiction:

Improvehair growth rateVSAvoidside effects and cost

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent applies parameter changes by identifying and optimizing the specific dose parameter range of 0.3 to 0.6 μg protein abundance per site. Within this range, the treatment achieves effective hair growth and skin regeneration without exceeding the threshold for adverse effects or unnecessary cost increase. This precise parameter optimization balances efficacy and safety.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent uses copying by referencing established safe dosing parameters from previous research and clinical observations, replicating the effective dose range that has been shown to produce beneficial effects without significant toxicity. This approach ensures that the treatment protocol is both effective and safe based on proven parameters.

Inventive Principle:

Principle #26Copying

Data Source

PatentUS20260014206A1Pharmaceutical composition for use in improving quality of scalp or skin, wound healing, or improving quality of hair

Publication Date: 2026.01.15 FUKUOKA HIROTARO

AI summary

The present invention provides a pharmaceutical composition for use in modifying scalp or skin, promoting wound healing, or modifying hair, comprising a secretion from adipose stem cells as an active ingredient, wherein 0.3 to 0.6 μg of the secretion in terms of protein abundance per site in scalp or skin is administered.